Kaleido Biosciences Inc (KLDO)

$0.01 +0.01 (100.00%)
Market Cap 6.39M
Revenue (ttm) 1.10M
Net Income (ttm) -90.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,178.26%
Debt to Equity Ratio 0.52
Volume 100
Avg Vol 5,978
Day's Range N/A - N/A
Shares Out 42.62M
Stochastic %K 12%
Beta -0.06
Analysts Hold
Price Target $11.85

Latest News on KLDO

No data available.